Statistical monitoring of data quality and consistency in the Stomach Cancer Adjuvant Multi-institutional Trial Group Trial

Timmermans, Catherine; Doffagne, Erik; Venet, David; Desmet, Lieven; Legrand, Catherine; Burzykowski, Tomasz; Buyse, Marc

doi:10.1007/s10120-015-0533-9

Article (Scientific journals)

Statistical monitoring of data quality and consistency in the Stomach Cancer Adjuvant Multi-institutional Trial Group Trial

Timmermans, Catherine; Doffagne, Erik; Venet, David et al.

2016 • In Gastric Cancer, 19 (1), p. 24-30

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/232599

DOI
10.1007/s10120-015-0533-9

PubMed
26298185

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Preprint_Timmermans_et_al_2015_GastricCancer_CSM_SAMIT.pdf

Author preprint (530.67 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Clinical trials

Abstract :

[en] Data quality may impact the outcome of clinical trials; hence, there is a need to implement quality control strategies for the data collected. Traditional approaches to quality control have primarily used source data verification during on-site monitoring visits, but these approaches are hugely expensive as well as ineffective. There is growing interest in central statistical monitoring (CSM) as an effective way to ensure data quality and consistency in multicenter clinical trials.

Disciplines :

Physical, chemical, mathematical & earth Sciences: Multidisciplinary, general & others
Human health sciences: Multidisciplinary, general & others

Author, co-author :

Timmermans, Catherine ; CluePoints S.A., Université Catholique de Louvain

Doffagne, Erik; CluePoints S.A

Venet, David; Brussels University > Institut de Recherches Interdisciplinaires et de De´veloppements en Intelligence Artificielle,

Desmet, Lieven; Université Catholique de Louvain - UCL

Legrand, Catherine; Université Catholique de Louvain - UCL

Burzykowski, Tomasz; International Drug Development Institute ; Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Hasselt University,

Buyse, Marc; CluePoints S.A ; International Drug Development Institute ; Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Hasselt University,

Language :

English

Title :

Statistical monitoring of data quality and consistency in the Stomach Cancer Adjuvant Multi-institutional Trial Group Trial

Publication date :

2016

Journal title :

Gastric Cancer

ISSN :

1436-3291

eISSN :

1436-3305

Publisher :

Springer, Germany

Volume :

Issue :

Pages :

24-30

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

https://link.springer.com/article/10.1007%2Fs10120-015-0533-9

Available on ORBi :

since 05 February 2019

Statistics

Number of views

72 (3 by ULiège)

Number of downloads

2 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Buyse M. Centralized statistical monitoring as a way to improve the quality of clinical trials. Appl Clin Trials. 2014. http://www.appliedclinicaltrialsonline.com/print/199784. Accessed 20 Feb 2015.
Morrison BW, Cochran CJ, White JG, Harley J, Kleppinger CF, Liu A, et al. Monitoring the quality of conduct of clinical trials: a survey of current practices. Clin Trials. 2011;8:342–9.
Smith CT, Stocken DD, Dunn J, Cox T, Ghaneh P, Cunningham D, et al. The value of source data verification in a cancer clinical trial. PLoS One. 2012;7:e51623.
Bakobaki JM, Rauchenberger M, Joffe N, McCormack S, Stenning S, Meredith S. The potential for central monitoring techniques to replace on-site monitoring: findings from an international multi-centre clinical trial. Clin Trials. 2012;9:257–64.
US Department of Health and Human Services, Food and Drug Administration. Guidance for industry: oversight of clinical investigations—a risk-based approach to monitoring. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM269919.pdf. Accessed 20 Feb 2015.
European Medicines Agency. Reflection paper on risk based quality management in clinical trials. EMA/INS/GCP/394194/2011. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500110059.pdf. Accessed 20 Feb 2015.
Baigent C, Harrel F, Buyse M, Emberson JR, Altman DG. Ensuring trial validity by data quality assurance and diversification of monitoring methods. Clin Trials. 2008;5:49–55.
Venet D, Doffagne E, Burzykowski T, Beckers F, Tellier Y, Genevois-Marlin E, et al. A statistical approach to central monitoring of data quality in clinical trials. Clin Trials. 2012;9:705–7013.
Kirkwood A, Cox T, Hackshaw A. Application of methods for central statistical monitoring in clinical trials. Clin Trials. 2013;10:783–806.
Edwards P, Shakur H, Barnetson L, Prieto D, Evans S, Robert I. Central and statistical monitoring in the clinical randomization of an antifibrinolytic in significant haemorrhage (CRASH_2) trial. Clin Trials. 2014;11:336–43.
Lindblad AS, Manukyan Z, Purohit-Sheth T, Gensler G, Okwesili P, Meeker-O’Connel A, et al. Central site monitoring: results from a test of accuracy in identifying trials and sites failing food and drug administration inspection. Clin Trials. 2014;11(2):205–17.
Pogue JM, Devereaux PJ, Thorlund K, Yusuf S. Central statistical monitoring: detecting fraud in clinical trials. Clin Trials. 2013;10:225–35.
Buyse M, George S, Evans S, Geller NL, Ranstan J, Scherrer B, et al. The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials. Stat Med. 1999;18:3435–51.
Evans S. Statistical aspects of the detection of fraud. In: Lock S, Wells F, Farthing M, editors. Fraud and misconduct in medical research. 3rd ed. London: BMJ Publishing Group; 2001. p. 186–204.
Buyse M, Evans S. Fraud in clinical trials. In: Armitage P, Colton T, editors. Encyclopaedia of biostatistics. New York: Wiley; 2005. p. 2023–31.
Al-Marzouki S, Evans S, Marshall T, Roberts I. Are these data real? Statistical methods for the detection of data fabrication in clinical trials. BMJ. 2005;331:267–70.
George SL, Buyse M. Data fraud in clinical trials. Clin Investig. 2015;15:161–73.
Tsuburaya A, Yoshida K, Kobayashi M, Yoshino S, Takahashi M, et al. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial. Lancet Oncol. 2014;15:886–93.